Tacrolimus Enhances the Invasion Potential of Hepatocellular Carcinoma Cells and Promotes Lymphatic Metastasis in a Rat Model of Hepatocellular Carcinoma: Involvement of Vascular Endothelial Growth Factor-C-Reference-Cited by-同舟云学术

Tacrolimus Enhances the Invasion Potential of Hepatocellular Carcinoma Cells and Promotes Lymphatic Metastasis in a Rat Model of Hepatocellular Carcinoma: Involvement of Vascular Endothelial Growth Factor-C

Published:2011-09 Issue:7 Volume:43 Page:2747-2754
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Zhou S.,Tan C.,Dai Z.,Zhu H.,Xu M.,Zhou Z.,Wang W.,Zhao Y.,Fu X.,Zhou J.,Fan J.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference36 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis;Bolondi;Gut,2001

3. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma;Bai;Hepatology,2009

4. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators;Zimmerman;Arch Surg,2008

5. Results of liver transplantation: with or without Milan criteria?;Mazzaferro;Liver Transpl,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative carcinogenicity of tacrolimus vs mycophenolate after solid organ transplantation and its implications for liver transplant care;World Journal of Hepatology;2024-04-27

2. Evolving challenges with long‐term care of liver transplant recipients;Clinical Transplantation;2023-08-07

3. Sirolimus Attenuates Calcineurin Inhibitor-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma;Transplantation Proceedings;2022-09

4. MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling;npj Genomic Medicine;2020-04-01

5. Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection;Cancer Immunology, Immunotherapy;2019-06-14